Last edition
News about "oncology drug discovery"
Symeres Partners Ambagon Therapeutics to Advance Molecular Glue Research for Cancer Treatment
The collaboration will evaluate novel small-molecule “molecular glues” to target colorectal cancer and other hard-to-treat diseases, aiming to expand next-generation drug discovery approaches.
Oncology Drug Discovery | 02/04/2026 | By News Bureau
Phanes Therapeutics Presents First Clinical Data for Spevatamig in Metastatic Pancreatic Cancer
Early data from the Twinpeak study presented at ASCO GI 2026 show encouraging safety and efficacy of spevatamig combined with chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma.
Oncology Drug Discovery | 12/01/2026 | By News Bureau | 150
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy